Filing Flows › Intellia Therapeutics (NTLA) › How it makes money
How Intellia Therapeutics (NTLA) makes money
Intellia Therapeutics (NTLA) made $7.2M of revenue in the third quarter 2026 (Q3 2026), -48% from a year earlier.
Drawing the Sankey…
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $7.2M | 100.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $7.2M | -48% |
| Q2 2026 | $7.7M | -46% |
| Q1 2026 | $15.0M | -10% |
| Q4 2025 | $23.0M | +79% |
| Q3 2025 | $13.8M | +51% |
| Q2 2025 | $14.2M | +105% |
| Q1 2025 | $16.6M | -42% |
From Intellia Therapeutics' 10-Q filed Nov 5, 2026 (on EDGAR).
Questions
How does Intellia Therapeutics make money?
Intellia Therapeutics (NTLA) made $7.2M of revenue in the third quarter 2026 (Q3 2026), -48% from a year earlier.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.